Design S20-183 mRNA Vaccines: Methods of Synthesis and Stability Assessment Rhiju Das Eesha Sharma Maria Barna Kathrin Leppek Gun woo Byeon S20-525 Platform for peptide vaccine sequence optimization Albert Wong S10-393 Cancer vaccine optimization with EGFRvIII-derived peptide Albert Wong S18-206 A STRATEGY FOR CREATING VACCINES TO ELICIT ANTIBODIES TARGETING A SPECIFIC EPITOPE Peter Kim Payton Weidenbacher S20-217 Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines Rhiju Das Do Soon Kim Jonathan Romano S19-111 Systems and Methods for Designing RNA Nanostructures + RNAMake software Rhiju Das Joseph Yesselman Kalli Kappel S20-175 Optimized Synthesis of RNA-based Therapeutic Candidates Maria Barna Kathrin Leppek Gun woo Byeon S20-176 Software for Rapid Mapping of RNA Structure Maria Barna Gun woo Byeon S20-135 Translation Enhancer for Gene Regulation Maria Barna Kathrin Leppek S21-056 "mRNA hotfix" rapidly re-code a stabilized mRNA to code for a protein mutant Rhiju Das Hannah Wayment-Steele S20-224 Algorithm for Maximizing mRNA Thermodynamic Stability Hannah Wayment-Steele Rhiju Das S19-020 MARIA-Neural network for accurate prediction of HLA class II antigen presentation Arash Alizadeh Russ Altman Binbin Chen Karan Kathuria Adjuvants S21-063 TLR7-agonist-nanoparticle vaccine adjuvant Qian Yin Mark Davis Wei Luo Bali Pulendran S20-530 Modulating the epigenome with adjuvants to stimulate broad and persistent innate immunity against diverse viruses Bali Pulendran Florian Wimmers Delivery & Formulation S16-157 CART- a transfection delivery system for efficient intracellular mRNA delivery Robert Waymouth Paul Wender Jessica Vargas Timothy Blake Colin McKinlay Ronald Levy Nancy Benner Katherine Keenan Ole Audun Haabeth S20-302 Intranasal, multivalent SARS-CoV-2 vaccine Ramasamy Paulmurugan Uday Kumar Sukumar Tarik Massoud Cancer Vaccines S20-039 Enhanced activation of CD8+ and CD4+ T cells by a vaccine targeting CD244 or CD48 Thomas Cherpes Rodolfo Vicetti Miguel S10-393 Cancer vaccine optimization with EGFRvIII-derived peptide Albert Wong S22-437 Hypoallogenic-Immunogenic Pluripotent Stem Cells as an Anti-cancer Vaccine Lin Wang Joseph Ching-Ming Wu S23-361 Pathogen-agnostic Vaccine Harnessing Integrated Organ Immunity Bali Pulendran Audrey Lee Infectious Disease Vaccines S20-279 A Three Component Vaccine for Covid-19 Ronald Levy Ole Audun Haabeth Adrienne Sallets Timothy Blake Paul Wender Robert Waymouth Debra Czerwinski Idit Sagiv-Barfi Julian Johannes Lohmeyer S23-361 Pathogen-agnostic Vaccine Harnessing Integrated Organ Immunity Bali Pulendran Audrey Lee
S20-183 mRNA Vaccines: Methods of Synthesis and Stability Assessment Rhiju Das Eesha Sharma Maria Barna Kathrin Leppek Gun woo Byeon
S18-206 A STRATEGY FOR CREATING VACCINES TO ELICIT ANTIBODIES TARGETING A SPECIFIC EPITOPE Peter Kim Payton Weidenbacher
S20-217 Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines Rhiju Das Do Soon Kim Jonathan Romano
S19-111 Systems and Methods for Designing RNA Nanostructures + RNAMake software Rhiju Das Joseph Yesselman Kalli Kappel
S20-175 Optimized Synthesis of RNA-based Therapeutic Candidates Maria Barna Kathrin Leppek Gun woo Byeon
S21-056 "mRNA hotfix" rapidly re-code a stabilized mRNA to code for a protein mutant Rhiju Das Hannah Wayment-Steele
S19-020 MARIA-Neural network for accurate prediction of HLA class II antigen presentation Arash Alizadeh Russ Altman Binbin Chen Karan Kathuria
S20-530 Modulating the epigenome with adjuvants to stimulate broad and persistent innate immunity against diverse viruses Bali Pulendran Florian Wimmers
S16-157 CART- a transfection delivery system for efficient intracellular mRNA delivery Robert Waymouth Paul Wender Jessica Vargas Timothy Blake Colin McKinlay Ronald Levy Nancy Benner Katherine Keenan Ole Audun Haabeth
S20-302 Intranasal, multivalent SARS-CoV-2 vaccine Ramasamy Paulmurugan Uday Kumar Sukumar Tarik Massoud
S20-039 Enhanced activation of CD8+ and CD4+ T cells by a vaccine targeting CD244 or CD48 Thomas Cherpes Rodolfo Vicetti Miguel
S22-437 Hypoallogenic-Immunogenic Pluripotent Stem Cells as an Anti-cancer Vaccine Lin Wang Joseph Ching-Ming Wu
S20-279 A Three Component Vaccine for Covid-19 Ronald Levy Ole Audun Haabeth Adrienne Sallets Timothy Blake Paul Wender Robert Waymouth Debra Czerwinski Idit Sagiv-Barfi Julian Johannes Lohmeyer